Kronox Lab Science Ltd Stock Price Today (NSE: KRONOX)

Kronox Lab Science Ltd

133.150.89 (0.66%)
Market Closed

Fundamental Score

...

Kronox Lab Science Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Kronox Lab Science Ltd share price today is 133.15, down 0.66% on NSE/BSE as of 19 June 2026. Kronox Lab Science Ltd (KRONOX) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 528.25 (Cr). The 52-week high for KRONOX share price is 207.49 and the 52-week low is 96.00. At a P/E ratio of 20.47x, KRONOX is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 32.57% and a debt-to-equity ratio of 0.03.

Kronox Lab Science Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
145.06
Low
124.71
Volume
54.5K
Change
+11.41%

Kronox Lab Science Ltd share price chart: 11.41% return over the past month. 52-week high ₹207.49, 52-week low ₹96.00.

Kronox Lab Science Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
133.67135.19130.53133.1532.35K (Cr)
138.60143.45133.21134.0457.53K (Cr)
144.94145.80138.00138.8781.51K (Cr)
140.53144.80138.65143.121.15L (Cr)
135.98144.00135.98138.7090.71K (Cr)
139.56140.39136.06136.8252.04K (Cr)
140.00141.90135.62136.8863.86K (Cr)
133.93136.00128.65134.2531.50K (Cr)
135.00135.00130.15132.1417.76K (Cr)
132.00135.00131.00132.0332.83K (Cr)

Kronox Lab Science Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
138.60143.45130.53133.15-3.93%
142.90145.80125.72138.87-2.82%
105.00146.9099.35140.62+33.92%
118.05118.9596.0097.02-17.81%
122.97132.59111.10119.83-2.55%
141.86142.20118.00122.53-13.63%
145.74147.20130.30139.74-4.12%
149.00154.95140.00142.88-4.11%
161.00161.99144.05148.29-7.89%
162.90180.50158.10160.01-1.77%
180.98183.52153.20161.53-10.75%
193.04207.49172.63180.98-6.25%

AI Research Briefing

Powered by Gemini · 2026-04-09

Micro-cap specialty chemical play with recent volatility and flat earnings; needs more data to confirm growth story.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSERecent volatility with a 1M decline of -3.88% and a 3M decline of -15.42% followed by a sharp rebound.P/E of 20.47x is lower than the industry P/E of 29.2x, suggesting it's fairly valued.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Kronox Lab Sciences saw significant share price volatility. On March 30, 2026, the stock hit a 52-week and all-time low of However, it rebounded strongly, gaining 16.27% between March 30 and April 2, closing at on April 2. The company issued a clarification on April 8, stating they are unaware of any specific reasons for the price movement and attribute it to market factors.

CORE STORY (THE REAL GAME)

Why Now
  • Recent sharp rebound after hitting all-time low.
  • Strong profitability ratios (ROE, ROCE).
  • Growth potential in the Indian specialty chemicals market.
Potential Catalysts
  • Significant new order wins.
  • Earnings beat expectations.
  • Capacity expansion announcements.
Key Risks
  • Micro-cap with inherent liquidity risk.
  • Recent flat earnings growth.
  • Company denies knowledge of reasons for share price volatility.
Institutional Activity

DII holdings increased slightly (Δ 0.22%), but FII holdings remain negligible (0.03%). Promoter holding is stable at 74.21%.

Macro Context

Indian specialty chemicals sector is expected to grow, driven by domestic demand and global supply chain shifts.

Cash Flow Quality

Free Cash Flow 5Y is ₹59.07 Cr, indicating profit converting to cash.

3–6 Month Outlook

Monitor near-term earnings for growth confirmation. A sustained breakout above ₹130 with volume could signal renewed bullish momentum.

Primary Thesis Risk

Lack of liquidity and flat earnings could derail the growth story.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

32.57%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

43.82%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

27.34%

Average operating profit margin over 5 years

Dividend Yield

0.35%

Annual dividend as % of current share price

Kronox Lab Science Ltd Valuation Check

Good

Price to Earnings (P/E)

20.47x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.20x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

74.21%

% shares held by company founders/management

Poor

FII Holding

0.03%

% shares held by foreign institutional investors

Poor

DII Holding

1.93%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

3.25%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

2.70%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

14.70%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-54.28%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

24.28%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.03x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

869.75x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

59.07 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Kronox Lab Science Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KRONOX across key market metrics for learning purposes.

Positive Indicators

11 factors identified

Strong Return on Equity (32.57%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (43.82%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (27.34%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 20.47 vs Industry: 29.20)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (14.70% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (24.28% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.03)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (869.75x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹59.07 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (74.21%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Weak Earnings Growth (-54.28% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Limited Institutional Interest (FII+DII: 1.96%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Kronox Lab Science Ltd vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Kronox Lab Science Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
60.9/100
133
₹528.25
20.5
Average
32.57%
Excellent
43.82%
Excellent
0.0
Excellent
24.28%
Excellent
14.70%
Good
0.35%
60.4/100
1481
₹149466.57
66.6
Average
23.05%
Excellent
29.84%
Excellent
0.1
Excellent
12.63%
Good
12.49%
Good
0.68%
51.5/100
3682
₹37241.99
54.8
Average
8.29%
Poor
9.89%
Poor
0.2
Excellent
21.05%
Excellent
12.69%
Good
0.09%
40.6/100
7245
₹29462.02
66.3
Average
11.52%
Average
11.68%
Average
0.3
Excellent
-6.59%
Poor
17.22%
Excellent
0.21%
40.2/100
1715
₹21083.64
39.7
Average
13.36%
Average
16.28%
Good
0.2
Excellent
2.02%
Average
14.38%
Good
0.49%
52/100
3430
₹17807.40
46.3
Average
13.73%
Average
18.02%
Good
0.0
Excellent
57.98%
Excellent
14.83%
Good
0.49%
Atul Ltd...
ATUL500027
50.5/100
7003
₹17066.13
31.5
Average
9.10%
Poor
12.81%
Average
0.0
Excellent
-5.82%
Poor
6.41%
Good
0.43%
57.2/100
1325
₹16256.72
35.0
Average
15.75%
Good
20.61%
Excellent
0.0
Excellent
4.46%
Average
16.92%
Excellent
0.48%
37.5/100
1368
₹14036.52
92.8
Average
3.32%
Poor
7.33%
Poor
0.4
Excellent
11.97%
Good
22.13%
Excellent
0.06%
41.9/100
501
₹13796.68
51.3
Average
6.03%
Poor
6.32%
Poor
0.7
Good
-9.09%
Poor
11.68%
Good
0.26%
60.5/100
4677
₹13359.76
33.4
Average
19.47%
Good
26.39%
Excellent
0.0
Excellent
20.04%
Excellent
16.93%
Excellent
0.25%

Kronox Lab Science Ltd PE Ratio History

Historical price-to-earnings ratio for KRONOX — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20256.91₹139.7420.2x
FY 20245.75₹199.7434.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Kronox Lab Science Ltd Dividend History

Annual cash dividends paid by KRONOX — dividend yield 0.35%

Financial YearDividends Paid (₹ Cr)
FY 20251.85 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Kronox Lab Science Ltd Quarterly Performance

Latest quarterly metrics for KRONOX — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

2.70%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

3.25%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

14.70%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

24.28%

Compounded annual net profit growth over 5 years

Kronox Lab Science Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KRONOX — calculated from daily price history

52RSI 14
Neutral — RSI 52

Momentum is balanced — neither overbought nor oversold.

SMA 50
127
▲ Price above SMA 50 — Short-term bullish
SMA 200
141
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
49K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Kronox Lab Science Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Kronox Lab Science Ltd (KRONOX) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Kronox Lab Science Ltd

About KRONOX (Kronox Lab Science Ltd)

Kronox Lab Science Ltd is a dynamic manufacturer specializing in a diverse array of high-purity specialty chemicals. The company operates with a core focus on crafting precision in...gredients that cater to a wide spectrum of industries. Their meticulous approach encompasses the production of inorganic and metallic chemicals alongside a comprehensive range of phosphates, all meticulously formulated to meet stringent quality standards. Kronox distinguishes itself through a commitment to innovation, continuously refining its processes to deliver chemicals that consistently exceed expectations. This dedication positions them as a trusted partner for businesses demanding excellence and reliability in their chemical inputs. The company’s product portfolio is strategically structured into three key categories, each addressing specific market demands. Their bulk reagents division provides essential chemicals with grades ranging from ACS to GR, catering to laboratory and research needs. The bulk ingredients segment focuses on supplying specialized compounds tailored for diverse applications, including oral care products, pharmaceuticals, and the ever-evolving food and nutraceutical industry. In addition to these, Kronox boasts a specialty chemicals division, where they synthesize complex compounds such as tartrates, citrates, and hypophosphites, showcasing their advanced capabilities in chemical synthesis. Each offering is supported by stringent quality control measures to ensure optimal purity and performance in its intended applications. Kronox Lab Science's global reach extends beyond India, solidifying its position as a prominent international supplier. They cultivate strong relationships with clients across various sectors, providing tailored solutions and unwavering support. By maintaining a keen awareness of evolving industry needs, Kronox proactively develops new products and refines existing ones to stay at the forefront of specialty chemical manufacturing. Their emphasis on sustainable practices and ethical sourcing underscores their commitment to responsible business operations, resonating with customers who value both quality and integrity. Kronox Lab Science is dedicated to advancing chemical science and delivering value to its customers worldwide.

Company Details

Symbol:KRONOX
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Jogindersingh Gianchand Jaswal
MD & Chairman
Mr. Ketan Ramani
Executive Whole-time Director
Mr. Pritesh Vinodchandra Ramani
Executive Whole-time Director

KRONOX Share Price: Frequently Asked Questions

What is the current share price of Kronox Lab Science Ltd?

Kronox Lab Science Ltd (KRONOX) trades at ₹133.15 on NSE and BSE. Market cap ₹528.25 (Cr). Educational data only.

What is the P/E ratio of Kronox Lab Science Ltd?

Kronox Lab Science Ltd has a P/E of 20.47x vs industry average 29.20x.

What is the Bull Run score for Kronox Lab Science Ltd?

Kronox Lab Science Ltd has a Bull Run score of 60.9/100 based on 25+ financial parameters.

Does Kronox Lab Science Ltd pay dividends?

Kronox Lab Science Ltd has a dividend yield of 0.35%. Past dividends don't guarantee future payments.

What is the ROE of Kronox Lab Science Ltd?

Kronox Lab Science Ltd has ROE of 32.57%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Kronox Lab Science Ltd?

Kronox Lab Science Ltd has debt-to-equity of 0.03.

Is Kronox Lab Science Ltd a good investment?

Bull Run gives Kronox Lab Science Ltd a score of 60.9/100. This is not investment advice — consult a SEBI-registered advisor.